GFC Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	5,616	7,470	1,538	1,186	141.89	977.2
Short-Term Investments	-	-	-	24	493.54	528.86
Trading Asset Securities	289.6	297.7	-	-	-	-
Cash & Short-Term Investments	5,905	7,768	1,538	1,210	635.43	1,506
Cash Growth	283.97%	405.09%	27.10%	90.42%	-57.81%	21.37%
Accounts Receivable	3,050	2,171	1,764	1,714	1,831	1,783
Other Receivables	12.07	3.95	1.39	2.51	7.23	240.38
Receivables	3,062	2,175	1,768	1,717	1,839	2,023
Inventory	1,004	575.82	517.94	632.12	671	481.4
Prepaid Expenses	86.29	88.54	5.35	72.38	245.77	37.73
Other Current Assets	513.13	706.79	118.38	67.84	72.01	88.64
Total Current Assets	10,570	11,314	3,947	3,699	3,463	4,137
Property, Plant & Equipment	21,662	19,499	14,501	12,797	16,057	14,698
Long-Term Investments	236.44	177.95	677.38	824.84	624.67	425.48
Other Intangible Assets	2,327	1,785	462.7	193.63	193.34	252
Long-Term Accounts Receivable	-0	-0	-	-	-	-
Long-Term Deferred Tax Assets	942.65	942.65	222.57	-	-	-
Other Long-Term Assets	107.41	115.11	236.88	508.45	629.85	628.57
Total Assets	35,846	33,833	20,055	18,023	20,967	20,141
Accounts Payable	334.94	250.36	248.93	303.07	430.56	440.44
Accrued Expenses	317.12	259.11	190.89	356.64	336.87	203.6
Short-Term Debt	-	-	5,000	5,084	1,580	500
Current Portion of Long-Term Debt	-	-	-	320.8	5,336	336.12
Current Portion of Leases	175.82	266.78	427.99	-	-	-
Current Income Taxes Payable	-	-	-	-	-	15.94
Current Unearned Revenue	-	-	-	14.14	14.14	21.55
Other Current Liabilities	1,386	1,245	999.48	919.21	2,436	893.84
Total Current Liabilities	2,213	2,021	6,867	6,998	10,133	2,411
Long-Term Debt	7,984	6,984	1,365	2,021	3,384	7,620
Long-Term Leases	251.89	271.68	229.09	-	-	-
Pension & Post-Retirement Benefits	469.41	449.76	407.87	698.62	562.32	187.67
Other Long-Term Liabilities	307.8	308.42	285.87	70	50	20
Total Liabilities	11,227	10,035	9,155	9,788	14,130	10,239
Common Stock	2,652	2,627	2,201	518.26	518.26	518.26
Additional Paid-In Capital	22,819	29,845	18,230	8,864	8,864	8,864
Retained Earnings	472.55	-7,441	-7,979	418.77	-1,128	1,804
Treasury Stock	-200	-200	-200	-200	-200	-
Comprehensive Income & Other	-1,125	-1,031	-1,352	-1,546	-1,397	-1,465
Total Common Equity	24,619	23,799	10,900	8,055	6,657	9,721
Shareholders' Equity	24,619	23,799	10,900	8,235	6,838	9,902
Total Liabilities & Equity	35,846	33,833	20,055	18,023	20,967	20,141
Total Debt	8,412	7,522	7,022	7,426	10,300	8,456
Net Cash (Debt)	-2,507	245.42	-5,484	-6,216	-9,665	-6,950
Net Cash Per Share	-496.79	50.95	-1726.30	-5996.61	-9325.18	-6707.09
Filing Date Shares Outstanding	5.3	5.24	3.49	1.04	1.04	1.04
Total Common Shares Outstanding	5.3	5.24	3.49	1.04	1.04	1.04
Working Capital	8,356	9,293	-2,920	-3,299	-6,670	1,725
Book Value Per Share	4643.12	4541.01	3122.48	7770.77	6423.20	9381.36
Tangible Book Value	22,292	22,014	10,437	7,861	6,464	9,469
Tangible Book Value Per Share	4204.28	4200.50	2989.93	7583.97	6236.66	9138.18
Land	5,485	5,092	4,065	3,813	4,770	4,770
Buildings	11,669	10,405	6,731	6,319	8,499	6,137
Machinery	9,300	8,842	7,535	5,455	4,951	3,441
Construction In Progress	525.04	288.63	130.87	18.93	44.61	2,534